INBS Q1 2025 Earnings EPS Misses Estimates as Company Reports No Revenue UHT Q1 2026 Earnings EPS Beats in Absence of Consensus Shares Edge Higher Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Surprises Analysts Amid RD Progress Upexi UPXI Q1 2026 Earnings Massive EPS Miss Highlights Operational Challenges NTRS Q1 2026 Earnings EPS Surges 143 Above Estimates Amid Solid Operating Performance FOA Q1 2026 Earnings Strong EPS Surprise of 2966 Drives Investor Attention Ingredion Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment DTE Energy Q1 2026 Earnings Earnings Miss Estimates as Costs Pressure Results PKX Q4 2025 Earnings Significant EPS Miss Amid Challenging Steel Market Conditions Xtant Medical Holdings Inc XTNT Q1 2026 Earnings EPS Misses Estimates Amidst Narrow Loss Kenon Holdings Q2 2025 Earnings Modest Profit Amid Quiet Quarter